FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

771591006: Tildrakizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3706923013 Tildrakizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3706924019 Tildrakizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tildrakizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Tildrakizumab Is a Substance with interleukin 23 receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Tildrakizumab Has disposition Interleukin 23 receptor antagonist true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing tildrakizumab in parenteral dose form (medicinal product form) Has active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier 1
Product containing tildrakizumab (medicinal product) Has active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier 1
Tildrakizumab Has active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier 1
Product containing only tildrakizumab in parenteral dose form (medicinal product form) Has active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier 1
Product containing precisely tildrakizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier 1
Product containing precisely tildrakizumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Tildrakizumab Inferred relationship Existential restriction modifier 1
Tildrakizumab 100mg/1ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier
Tildrakizumab 100mg/1ml solution for injection pre-filled syringes 2 pre-filled disposable injection Has specific active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier
Ilumetri 100mg/1ml solution for injection pre-filled syringes (Almirall Ltd) 1 pre-filled disposable injection Has specific active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier
Ilumetri 100mg/1ml solution for injection pre-filled syringes (Almirall Ltd) Has specific active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier
Tildrakizumab 100mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier
Ilumetri 100mg/1ml solution for injection pre-filled syringes (Almirall Ltd) 2 pre-filled disposable injection Has specific active ingredient True Tildrakizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start